Systemic inflammation and proinflammatory interleukin-17 signalling persist at the end of therapy in patients with metabolic syndrome and psoriasis, reducing the length of remission

Coimbra, S.; Oliveira, H.; Neuparth, M. J.; Proença, J. B.; Figueiredo, A.; Rocha-Pereira, P.; Santos-Silva, A.

doi:10.1111/bjd.14013

Title: Systemic inflammation and proinflammatory interleukin-17 signalling persist at the end of therapy in patients with metabolic syndrome and psoriasis, reducing the length of remission

Authors:

Coimbra, S. ^[1]; Oliveira, H. ^[2]; Neuparth, M. J. ^[3]; Proença, J. B. ^[3]; Figueiredo, A. ^[2]; Rocha-Pereira, P. ^[4]; Santos-Silva, A. ^[5]

UCIBIO@REQUIMTE, Departamento de Ciências Biológicas, Laboratório de Bioquímica, Faculdade de Farmácia (FFUP), Universidade do Porto, R. Jorge Viterbo Ferreira 228 4050-313 Porto Portugal, CESPU, Instituto de Investigação e Formação Avançada em Ciências e Tecnologias da Saúde, Gandra-PRD Portugal
Serviço de Dermatologia, Centro Hospitalar e Universitário de Coimbra, Universidade de Coimbra, Coimbra Portugal
CESPU, Instituto de Investigação e Formação Avançada em Ciências e Tecnologias da Saúde, Gandra-PRD Portugal
Centro de Investigação em Ciências da Saúde (CICS), Universidade da Beira Interior, Covilhã Portugal
UCIBIO@REQUIMTE, Departamento de Ciências Biológicas, Laboratório de Bioquímica, Faculdade de Farmácia (FFUP), Universidade do Porto, R. Jorge Viterbo Ferreira 228 4050-313 Porto Portugal

Publication Date:: Wed Nov 18 00:00:00 EST 2015

Sponsoring Org.:: USDOE Office of Nuclear Energy (NE), Fuel Cycle Technologies (NE-5)

OSTI Identifier:: 1400924

Grant/Contract Number:: OBS/58600/2004

Resource Type:: Publisher's Accepted Manuscript

Journal Name:: British Journal of Dermatology

Additional Journal Information:: Journal Name: British Journal of Dermatology Journal Volume: 174 Journal Issue: 2; Journal ID: ISSN 0007-0963

Publisher:: Wiley-Blackwell

Country of Publication:: United Kingdom

Language:: English

Citation Formats


                    Coimbra, S., Oliveira, H., Neuparth, M. J., Proença, J. B., Figueiredo, A., Rocha-Pereira, P., and Santos-Silva, A. Systemic inflammation and proinflammatory interleukin-17 signalling persist at the end of therapy in patients with metabolic syndrome and psoriasis, reducing the length of remission.  United Kingdom: N. p., 2015. 
Web.  doi:10.1111/bjd.14013.

Copy to clipboard


                    Coimbra, S., Oliveira, H., Neuparth, M. J., Proença, J. B., Figueiredo, A., Rocha-Pereira, P., & Santos-Silva, A. Systemic inflammation and proinflammatory interleukin-17 signalling persist at the end of therapy in patients with metabolic syndrome and psoriasis, reducing the length of remission.  United Kingdom.  https://doi.org/10.1111/bjd.14013

Copy to clipboard


                    Coimbra, S., Oliveira, H., Neuparth, M. J., Proença, J. B., Figueiredo, A., Rocha-Pereira, P., and Santos-Silva, A. Wed .  
"Systemic inflammation and proinflammatory interleukin-17 signalling persist at the end of therapy in patients with metabolic syndrome and psoriasis, reducing the length of remission".  United Kingdom.  https://doi.org/10.1111/bjd.14013.

Copy to clipboard


                    
@article{osti_1400924,

  title        = {Systemic inflammation and proinflammatory interleukin-17 signalling persist at the end of therapy in patients with metabolic syndrome and psoriasis, reducing the length of remission},

  author       = {Coimbra, S. and Oliveira, H. and Neuparth, M. J. and Proença, J. B. and Figueiredo, A. and Rocha-Pereira, P. and Santos-Silva, A.},

  abstractNote = {},

  doi          = {10.1111/bjd.14013},

  journal      = {British Journal of Dermatology},

  number       = 2,

  volume       = 174,

  place        = {United Kingdom},

  year         = {Wed Nov 18 00:00:00 EST 2015},

  month        = {Wed Nov 18 00:00:00 EST 2015}

}

Copy to clipboard

Journal Article:

Free Publicly Available Full Text

Accepted Manuscript (Publisher)

Publisher's Version of Record
https://doi.org/10.1111/bjd.14013

Other availability

Search WorldCat to find libraries that may hold this journal

Citation Metrics:

Cited by: 6 works

Citation information provided by
Web of Science

Save / Share:

Export Metadata

Save to My Library

Works referenced in this record:

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation
journal, July 1998

Alberti, K. G. M. M.; Zimmet, P. Z.
Diabetic Medicine, Vol. 15, Issue 7
DOI: 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S

Similar Records in DOE PAGES and OSTI.GOV collections:

Metaproteomics reveals persistent and phylum-redundant metabolic functional stability in adult human gut microbiomes of Crohn’s remission patients despite temporal variations in microbial taxa, genomes, and proteomes

Journal Article Blakeley-Ruiz, J. Alfredo ; Erickson, Alison R. ; Cantarel, Brandi L. ; ... - Microbiome

Background The gut microbiome plays a fundamental role in the human host’s overall health by contributing key biological functions such as expanded metabolism and pathogen defense/immune control. In a healthy individual, the gut microbiome co-exists within the human host in a symbiotic, non-inflammatory relationship that enables mutual benefits, such as microbial degradation of indigestible food products into small molecules that the host can utilize, and enhanced pathogen defense. In dysbiotic conditions, this favorable metabolic relationship breaks down and a variety of undesirable activities result, including chronic inflammation and other health-related issues. It has been difficult, however, to elucidate the overallmore »« less
Cited by 40
https://doi.org/10.1186/s40168-019-0631-8

Full Text Available
The cross-talk between renal function, inflammation and psoriasis vulgaris

Journal Article Coimbra, S. ; Oliveira, H. ; Rocha-Pereira, P. ; ... - British Journal of Dermatology
Cited by 1
https://doi.org/10.1111/bjd.14913
Translocations (5; 17) and (7; 17) in patients with de novo or therapy-related myelodysplastic syndromes or acute nonlymphocytic leukemia. A possible association with acquired pseudo-Pelger-Hut anomaly and small vacuolated granulocytes

Journal Article La, J L.Z. ; Zandecki, M ; Fenaux, P ; ... - Cancer Genetics and Cytogenetics; (USA)

Twelve patients (two with de novo myelodysplastic syndrome (MDS), four with secondary MDS, five with de novo acute nonlymphocytic leukemia (ANLL), one with secondary ANLL) showed a 17p deletion resulting from translocations involving 17p: t(5;17)(p11;p11) in four cases, t(7;17)(p11;p11) in six cases, complex (5;17)(q23;p12) translocation with dicentric chromosome in one case, and t(17; )(p11-12; ) in the remaining patient. All these structural anomalies were observed in hypodiploid clones associated with total or partial monosomy of chromosomes 5 and 7 (12 cases), monosomy 12 (five cases), monosomy 3 (four cases), and monosomy 4 (three cases). Median survival was only 3.3 monthsmore »« less
https://doi.org/10.1016/0165-4608(90)90102-G
Patients with idiopathic endplate inflammation displayed aberrant Th17 responses resulting in proinflammatory monocyte activation

Journal Article Wang, Jian ; Sun, Wanju ; Bond, Allen ; ... - Experimental Cell Research

Endplate inflammation remains a difficult task to diagnose and treat, partly due to the absence of in-depth understanding of the cellular and molecular factors driving this condition. In the current study, we investigated the circulating immune cells in patients with idiopathic endplate inflammation. Compared to healthy controls, the patients with endplate inflammation presented a significant upregulation of Th17 cells, characterized by higher frequencies of circulating IL-17{sup +}CD4{sup +} T cells examined directly ex vivo and after PMA and ionomycin (PMA/I) stimulation. The frequency of Th17 cells in patients was not correlated with patient age, sex, or smoking status, but wasmore »« less
https://doi.org/10.1016/J.YEXCR.2018.01.006
Biochanin-A antagonizes the interleukin-1β-induced catabolic inflammation through the modulation of NFκB cellular signaling in primary rat chondrocytes

Journal Article Oh, Ji-Su ; Cho, In-A ; Kang, Kyeong-Rok ; ... - Biochemical and Biophysical Research Communications

Biochanin-A, a phytoestrogen derived from herbal plants, protected from the IL-1β-induced loss of proteoglycans through the suppression of matrix degrading enzymes such as matrix metalloproteinase (MMP)-13, MMP-3, MMP-1, and ADAMTS-5 in primary rat chondrocytes and the knee articular cartilage. It also suppressed the expression of IL-1β-induced catabolic factors such as nitric oxide synthase 2, cyclooxygenase-2, prostaglandin E{sub 2}, and inflammatory cytokines. Furthermore, biochanin-A suppressed the IL-1β-induced phosphorylation of NFκB, and inhibited its nuclear translocation in primary rat chondrocytes. These results indicate that biochanin-A antagonizes the IL-1β-induced catabolic effects through its anti-inflammatory activity that involves the modulation of NFκB signaling. -more »« less
https://doi.org/10.1016/J.BBRC.2016.06.126

Similar Records

Title: Systemic inflammation and proinflammatory interleukin-17 signalling persist at the end of therapy in patients with metabolic syndrome and psoriasis, reducing the length of remission

Citation Formats

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation journal, July 1998

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation
journal, July 1998